WO2004089188A2 - Vortex transducer - Google Patents

Vortex transducer Download PDF

Info

Publication number
WO2004089188A2
WO2004089188A2 PCT/US2004/010253 US2004010253W WO2004089188A2 WO 2004089188 A2 WO2004089188 A2 WO 2004089188A2 US 2004010253 W US2004010253 W US 2004010253W WO 2004089188 A2 WO2004089188 A2 WO 2004089188A2
Authority
WO
WIPO (PCT)
Prior art keywords
transducer
vortex
elements
piezoelectric
epoxy
Prior art date
Application number
PCT/US2004/010253
Other languages
French (fr)
Other versions
WO2004089188A3 (en
Inventor
Charles S. Desilets
Jens U. Quistgaard
Original Assignee
Liposonix, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liposonix, Inc. filed Critical Liposonix, Inc.
Priority to JP2006509648A priority Critical patent/JP2006521902A/en
Priority to EP04749694A priority patent/EP1608267A4/en
Publication of WO2004089188A2 publication Critical patent/WO2004089188A2/en
Publication of WO2004089188A3 publication Critical patent/WO2004089188A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00Diagnosis using ultrasonic, sonic or infrasonic waves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00Ultrasound therapy
    • A61N7/02Localised ultrasound hyperthermia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00Ultrasound therapy
    • A61N2007/0004Applications of ultrasound therapy
    • A61N2007/0008Destruction of fat cells

Definitions

  • the present invention relates to an ultrasound transducer for the use in high intensity focused ultrasound (HIFU) applications for medical applications.
  • HIFU high intensity focused ultrasound
  • Lysis the process of disintegration or dissolution of human tissue using high intensity focused ultrasound (HIFU) is a technique that has been studied for over 50 years.
  • Research into applications of HIFU have revolved mostly around treating malignant tumors in the body either untreatable by other means, or promising a more efficacious treatment modality.
  • HIFU commercialization has been very slow to develop, however, despite some of its early promise.
  • Reasons for this include the inability to visualize the lesions being formed, the necessity of having to lyse an entire malignant tumor to be considered effective, and especially the extended period of time required to lyse a significant volume of tissue.
  • FIG. 1 Cross-sectional histological views of a HIFU lesion formed in vivo in porcine adipose tissue are shown at 40X (Fig. 1) and at 200X (Fig. 2). Tri-chrome staining is employed. Lysed tissue shows blood perfusion around individual fat cells and incursion of phagocytes and red blood cells into the HIFU-treated volume. Lesions formed with HIFU are typically cigar-shaped, with lesions lengths being 5-8 times the diameters. HIFU lesions are typically formed by spherically focusing an ultrasonic beam created by driving electrically a piezoelectric material, causing it to vibrate. These lesions can be as little as 1-2 mm in diameter, and 6-10 mm in length.
  • Hynynen et. al. Fjield, T., V. Sorrentino, H. Cline, and K. Hynynen, "Design and experimental verification of thin acoustic lenses for the coagulation of large tissue volumes", Phys. Med. Biol, Vol 42, 1997, pp. 2341-2354.
  • Fjield, T. and K. Hynynen "Experimental Verification of the Sectored Annular Phased Array for MRI Guided
  • This concept dubbed the sector- vortex array, has been implemented using electronic array techniques or simply adding a mechanical sector-vortex lens onto the front of a planar transducer.
  • the effect of this lens is to create a double-cone field pattern that yields an annular ring in cross-section.
  • Spherical focusing is typically achieved by bonding a plano-concave lens on to the front of a planar piezoelectric material, or shaping the piezoelectric material into a spherical bowl.
  • High ultrasonic intensities 1-4 kW/cm 2
  • Absorption of this energy by tissue elevates its temperature. Raising this temperature in excess of 60°C in the focal zone coagulates cell proteins, thereby ablating the tissue.
  • thermo-mechanical means If the intensity is high enough, the temperature rise is sufficient to cause boiling and the production of small bubbles, producing a lesion with the elongated shape of a weather balloon at high altitudes ("tadpole" shape to others). At an even higher threshold, inertial cavitation (bubble creation) may occur, which can lyse tissue through thermo-mechanical means.
  • the epoxy filler then will fully cure, and further heat treatment can elevate the epoxy glass transition temperature, the temperature at which the polymer suddenly will soften, to levels between 120° and 200°C.
  • the material thus formed is relatively low loss and capable of handling HIFU power levels, albeit with less efficiency than solid, high power, piezoelectric ceramics.
  • f opt is the optimum frequency
  • is the ultrasonic absorption of fat
  • z is the tissue depth to be treated.
  • the optimum frequency for maximum heat deposition is 4.2 MHz. Other considerations may change the actual operating frequency, of course.
  • Sector-vortex array design has been extensively described and simulated by Cain and Umemura, Umemura and Cain, and numerous papers from Hynynen and co-workers at Brigham's and Women's Hospital at Harvard. They describe an implementation whereby the driving electrode of a spherical radiator is divided into N number of equal sized, pie-shaped sectors. Following Cain, driving signals are applied to the N sectors with a phase distribution over the N sectors determined by:
  • sector- vortex designs require complex electronics to drive the transducers in order to produce the vortex focal field.
  • the electronics are required to drive either sector transducers or phased arrays in sequence.
  • Some prior teachings rely on ancillary technologies such as the use of MRI machines to detect hotspots, and provide for additional electronic to provide real time corrections in the electronic firing of the various transducer elements to eliminate or reduce the occurrence of out-of-field ultrasound excitation.
  • Complex lenses have also been described to facilitate the steering of the ultrasound energy into the body.
  • Yet another objective is to provide for a vortex transducer with a cheap and cost effective manufacturing process.
  • One or more of the above objectives is met utilizing a mechanically formed vortex ultrasound transducer capable of producing at least one, substantially annular focal region when the transducer is excited.
  • a mechanically formed ultrasound transducer comprising a plurality of piezoelectric elements suspended in a polymer, and having an irregular shape in order to produce a vortex focal field.
  • the polymer used in the creation of a heat set transducer shape has a liquid state when introduced into a diced piezoelectric ceramic, a semi solid state during processing and a fixed solid state upon completion of a heat treatment step.
  • a method of manufacturing comprising the steps of first shaping a piezoelectric ceramic into a desired form, the form having a front end and a back end. Second dicing the front end to create a plurality of elements, the elements being attached to the back end and separated by dicing channels. Third, filling the dicing channels with a polymer material and allowing the polymer to gel. Fourth, creating a transducer form by removing the back end such that the elements are separated from one another. Fifth, pressing the transducer form into a mold and heating the transducer form such that the resin is heated above the B- stage and allowing the resin to cross-link and cool in a set shape.
  • An additional step involves the formation of a shaped irregularity to produce the vortex effect. This step can be inserted into the steps above where ever desired and there is no best order for the introduction of this step.
  • the shaped irregularity can be part of the original forming of the transducer form, or it can be created later by cutting or grinding the transducer form such that the desired irregularity is introduced.
  • FIG. 1 is a histological view of a HIFU lesion in porcine adipose tissue at 40X magnification.
  • Fig 2 is a histological view of a HIFU lesion in porcine adipose tissue at 200X magnification.
  • FIG. 3 is a schematic illustration of a vortex ultrasound transducer/applicator design in accordance with the present invention.
  • Figs. 4a-4d show a cross-sectional focal zone intensity distributions for a series of sector- vortex applicators, modes 0 through 3, demonstrating the annular structure of the field patterns and the widening of the annulus as a function of mode number.
  • FIGs. 5a and 5b is a further illustration of an embodiment of the present invention.
  • Figs. 6a-6g illustrate a process for making transducers in accordance with the present invention.
  • Described herein is an implementation of a version of the sector- vortex concept. While this concept is known, this disclosure implements the design in a novel manner.
  • a continuous vortex lens can be incorporated into the piezoelectric transducer material itself. This can be done by building the transducer out of piezoelectric composite material which can be molded into a vortex lens. This eliminates the need for complex driving electronics and all the issues of an external lens. This design could be instrumental in building cheap, reliable devices that can potentially reduce treatment time by factors of two to eight.
  • the present invention implements an applicator design that incorporates the phase shifts mechanically, not electronically. This is mathematically equivalent to letting N- ⁇ oo, that is letting the number of sectors become infinite, or making a continuously curving shape, as shown in Fig. 3, that yields a 2 ⁇ m phase shift after one revolution.
  • the applicator would also be preset with spherical focus. As one can see, this shape would be difficult to machine in a solid piezoelectric ceramic material. But one can easily imagine molding a piezocomposite into this shape using steel molds manufactured with a ball end mill or EDM (electric discharge machining) machine.
  • Fig. 3 also illustrates the generic shape of a continuously variable sector-vortex applicator made by splitting a spherical bowl along a radius and translating one split edge axially in relationship to the other edge.
  • the discontinuity at the split on the edge of the spherical bowl would then be 380 ⁇ m, mode 2, 760 ⁇ m, and so on.
  • Fig. 4a-4d show the cross-sectional focal patterns for modes 0, 1, 2, and 3, respectively.
  • Mode 0 reduces just to the simple spherical radiator, and serves as the standard by which to judge the increase in focal zone area in other designs.
  • the present invention comprises a mechanically formed vortex ultrasound transducer capable of producing at least one, substantially annular focal region(s) when said transducer is excited.
  • the transducer may incorporate a solid piezoelectric material or a composite piezoelectric material. Furthermore the transducer may incorporate one or more matching layers.
  • the transducer may incorporate a filler material in front of the transducer or backing material in back of the transducer.
  • the transducer may also be formed from a single contiguous piezoelectric element. See Figs. 5a & 5b, where the reference numbers are as follows:
  • a method of making the transducer of the present invention comprises the steps of: first shaping a piezoelectric ceramic into a desired form, the form having a front end and a back end. Second dicing the front end create a plurality of elements, the elements being attached to the back end and separated by dicing channels. Third filling the dicing channels with a resin material and allowing the resin to gel. Fourth, creating a transducer form by removing the back end such that the elements are separated from one another. Fifth, pressing the transducer form into a mold and heating the transducer form such thai the resin is heated above the B-state and allowing the resin to cross link and cool in a set shape.
  • An additional step involves the formation of a shaped irregularity to produce the vortex effect. This step can be inserted into the steps above where ever desired and there is no best order for the introduction of this step.
  • the shaped irregularity can be part of the original forming of the transducer form, or it can be created later by cutting or grinding the transducer form such that the desired irregularity is introduced.
  • the piezoelectric material is formed into a desired form (Fig. 6a).
  • the form may include the irregularity used to mechanically create the vortex transducer effect, or the irregularity can be introduced into the finished transducer form.
  • the shaping of the piezoelectric ceramic into a desired form follows procedures well established in the art of making ultrasound transducers.
  • the principal embodiment calls for a flat shape having sufficient size to be later molded into the desired three dimensional form. Otherwise there is no restriction or requirement on the formation process.
  • the dicing of the ceramic is also well known.
  • the ceramic is diced such that there is sufficient depth in the dicing channels to allow a resin like material to fill the channels (Fig. 6b).
  • a polymer e.g. epoxy or urethane
  • a polymer e.g. epoxy or urethane
  • the back plate is removed (Fig. 6d).
  • the transducer form comprises the individual elements and the polymer used to suspend the elements and hold them in place.
  • the resulting two-phase composite material can be tailored to have a number of interesting electro-mechanical and purely mechanical properties by the choice of parameters like ceramic volume fraction and polymer filler material.
  • hardset high durometer thermoset resin systems
  • epoxy as the polymer filler.
  • the set epoxy in the composite can be partially cured at a relatively low temperature where it "gels," or turns substantially solid from a liquid state. At a slightly higher temperature, the epoxy can then progress into a B-stage partially cross-linked cure which is quite hard, but very brittle. At this level the piezocomposite can be processed easily by grinding to a thickness as a flat plate and applying electrodes.
  • the piezocomposite can then be reheated slightly past the B-stage temperature where it softens considerably and can be formed into shapes.
  • the piezocomposite is placed in a warm bottom half of a mold that allows the plate to take the shape of the mold, a top half of the mold is then clamped to the bottom half, and then the mold is heated to a high final curing temperature.
  • the epoxy filler cures to a fully cross-linked, tempered, stage over a period of time determined by the resin system.
  • the resulting molded piezocomposite now has a shape that takes on the shape of a lens. In this manner, a piezoelectrically active lens can be made that is quite rugged, eliminating the need for separate focusing lenses.
  • the next step provides an essential process step of the present invention. That is the molding of the transducer form to shape the elements and polymer (epoxy) combination into a shaped transducer (Fig. 6e).
  • the form selected will dictate the focal range, depth and shape of the ultrasound focal zone. Thus the mold must be carefully determined and created since it is not possible to electronically steer the transducer when it is completed.
  • the mold and transducer form are heated until the resin/epoxy is heated past the B-stage of the filler material. This makes the epoxy/resin softer so the transducer form can be properly shaped.
  • the final shaped transducer (Fig. 6f) is then coated with a conductive material and electronically connected (Fig. 6g) to an activation device such as a high voltage supply (not shown).
  • the transducer can be made to operate either narrowband (roughly, at one frequency) or broadband (over a range of frequencies).
  • narrow or broadband will be left to the designer to choose based on the specific application.
  • the designer should consider the beam pattern the vortex transducer will produce before finalizing the design.
  • the beam shape will produce a double funnel focus field similar to that described in the prior art; however, with the simplified transducer of the present invention, there will be no need for complex electronics to steer or focus the beam, or run a complex pattern of individual element activations.

Abstract

A mechanically formed vortex transducer is described. The transducer has a plurality of piezoelectric elements suspended in an epoxy and heat molded into a desired shape. An irregularity in the transducer shape provides for a mechanically induced vortex focal field without the need for electronic steering or lens focusing. A system and methods of making the same are also described.

Description

VORTEX TRANSDUCER
BACKGROUND OF THE INVENTION [0001] 1. Field of the Invention. The present invention relates to an ultrasound transducer for the use in high intensity focused ultrasound (HIFU) applications for medical applications.
[0002] 2. Description of the Background Art. Lysis (the process of disintegration or dissolution) of human tissue using high intensity focused ultrasound (HIFU) is a technique that has been studied for over 50 years. Research into applications of HIFU have revolved mostly around treating malignant tumors in the body either untreatable by other means, or promising a more efficacious treatment modality. HIFU commercialization has been very slow to develop, however, despite some of its early promise. Reasons for this include the inability to visualize the lesions being formed, the necessity of having to lyse an entire malignant tumor to be considered effective, and especially the extended period of time required to lyse a significant volume of tissue. In the last 10 years or so, some companies have been formed to commercialize HIFU for non-cancerous treatment applications. The best-known example is the treatment of enlarged prostate or BPH. Here, it is not necessary to lyse all the tissue to be effective. Advances in the treatment of BPH with drugs, however, has seriously shrunk the commercial prospects for this case. Advances in MRI and diagnostic ultrasound in the last 20 years have aided visualization of HIFU lesions, alleviating a main obstacle to the commercial advancement of the field. Additionally, where small volumes of tissue can be treated, as in hemostasis and blood clot breakup, HIFU is likely to prove to be viable commercially. Lysing large volumes of tissue, as in the case of removing significant amounts of adipose tissue, requires additional technical strategies.
[0003] Cross-sectional histological views of a HIFU lesion formed in vivo in porcine adipose tissue are shown at 40X (Fig. 1) and at 200X (Fig. 2). Tri-chrome staining is employed. Lysed tissue shows blood perfusion around individual fat cells and incursion of phagocytes and red blood cells into the HIFU-treated volume. Lesions formed with HIFU are typically cigar-shaped, with lesions lengths being 5-8 times the diameters. HIFU lesions are typically formed by spherically focusing an ultrasonic beam created by driving electrically a piezoelectric material, causing it to vibrate. These lesions can be as little as 1-2 mm in diameter, and 6-10 mm in length. It would take many lesions to necrose a large volume of tissue. Preferred thermal processes are generally slow, so that it may take up to 30 seconds to generate enough absorption of the ultrasonic energy to raise the temperature high enough to necrose tissue, and additional time to allow the temperature of tissue between the skin and treated volume to cool sufficiently before the next lesion is created. A simple calculation shows that it could take hours to ablate a volume of tissue on the order of 250cc with a single transducer making individual lesions. Diminishing the time required to ablate a large volume of tissue, as in adipose tissue reduction, could mean the difference between a successful commercial product and an unsuccessful one.
[0004] Several strategies can be employed to reduce the time between making individual lesions, such as using multiple, mechanically scanned HIFU transducers, scanning the transducer(s) continuously, and/or using some kind of linear or 2D transducer array or structure to generate multiple focal spots. While some combination of these strategies could be employed, a major physical limitation of reducing scanning time remains the small diameter of the focused ultrasound beam. A defocusing strategy holds some promise of increasing the effective spot size by spreading the energy more laterally than lengthwise, creating a more spherical-shaped lesion. "Wobbling" the HIFU transducer mechanically about its axis could serve to do this, and such ideas have been reported in the literature. However, it would be certainly less complicated and expensive to build the defocusing into the HIFU transducer itself.
[0005] A method of creating an annular focal zone where the diameter of the annulus is adjustable has been reported by Cain and Umemura (Cain, Charles A. and Shin-Ichiro Umemura, "Concentric-Ring and Sector- Vortex Phased- Array Applicators for Ultrasound Hyperthermia", IEEE Trans, on Microwave Theory and Techniques, Vol MTT-34, No. 5, May 1986, pp. 542-551.) and (Umemura, Shin-Ichiro and CA. Cain, "The Sector- Vortex Phased Array: Acoustic Field Synthesis for Hyperthermia", IEEE Trans, on Ultrasonics, Ferroelectrics, and Frequency Control, Vo. 36, No. 2, March 1989, pp. 249-257.) and Hynynen et. al. (Fjield, T., V. Sorrentino, H. Cline, and K. Hynynen, "Design and experimental verification of thin acoustic lenses for the coagulation of large tissue volumes", Phys. Med. Biol, Vol 42, 1997, pp. 2341-2354.) and (Fjield, T. and K. Hynynen, "Experimental Verification of the Sectored Annular Phased Array for MRI Guided
Ultrasound Surgery", Proc 1996 IEEE Ultrasonics Symposium, pp. 1273-1276.) and (Fjield, T. and K. Hynynen, "The Combined Concentric-Ring and Sector- Vortex Array for MRI Guided Ultrasound Surgery", IEEE Trans, on Ultrasonics, Ferroelectrics, and Frequency Control, Vo. 44, No. 5, September 1997, pp. 1157-1167.) and (Fjield, T., N. McDannold, C. Silcox, and K. Hynynen, "In Vivo Verification of the Acoustic Model Used to Predict Temperature Elevations for MRI Guided Ultrasound Surgery", Proc 1998 IEEE Ultrasonics Symposium, pp. 1415-1418.). This concept, dubbed the sector- vortex array, has been implemented using electronic array techniques or simply adding a mechanical sector-vortex lens onto the front of a planar transducer. The effect of this lens is to create a double-cone field pattern that yields an annular ring in cross-section.
[0006] Extensive research with mechanically scanned, spherically focused transducers has been conducted in HIFU fat-tissue mimicking gel phantoms and in vivo porcine adipose tissue. The purpose of this research is to determine basic design parameters for optimizing the lysing of subcutaneous adipose tissue and develop candidate lysing and scanning protocols for inclusion into a product development specification and initial human safety trials. This research has shown that challenges remain in reducing the overall treatment time to the desired values. While various scanning strategies have proven fruitful in reducing the heat build-up tissue in the zone between the skin and HIFU-created focal volume, and thus reducing scanning time, even greater efficacy can be shown if the focal zone overall diameter is increased significantly. Transducers with built-in vortex capability could prove to be a relatively simple, cost-effective means to achieve this capability.
[0007] Spherical focusing is typically achieved by bonding a plano-concave lens on to the front of a planar piezoelectric material, or shaping the piezoelectric material into a spherical bowl. High ultrasonic intensities (1-4 kW/cm2) are created driving the piezoelectric material at very high power levels, and focusing the beam very tightly. Absorption of this energy by tissue elevates its temperature. Raising this temperature in excess of 60°C in the focal zone coagulates cell proteins, thereby ablating the tissue. There is a very sharp line between ablated and unablated tissue, as seen in Fig. 1. If the intensity is high enough, the temperature rise is sufficient to cause boiling and the production of small bubbles, producing a lesion with the elongated shape of a weather balloon at high altitudes ("tadpole" shape to others). At an even higher threshold, inertial cavitation (bubble creation) may occur, which can lyse tissue through thermo-mechanical means.
[0008] Lesions made in vivo in porcine tissue with spherically focused transducers show remarkably similar characteristics to those made in adipose tissue. Cigar-shaped lesions are made at relatively low power levels at longer insonification times, following the 6 dB contour of a classically spherically focused lens, and elongated weather balloon-shaped lesions are made at relatively high power levels where suspected boiling creates bubbles which reflect acoustic power back to the skin surface. At very high power levels, or too long insonification times, excessive heat can be generated above the focal zone which will lyse tissue up to and including the skin surface. While large volumes of tissue can be lysed in this manner, controlling this type of lesion growth can be problematic when considering patient and environmental variability.
[0009] Reducing the focal intensity at the center of the lesion and spreading the energy out over a larger volume should help alleviate the creation of a boiling hot spot while allowing more energy to be deposited during an insonification period, ultimately reducing the scanning time.
[0010] Composite piezoelectric materials have been a subject of research and development for nearly 25 years. Ultrasonic transducers and arrays for diagnostic imaging purposes have been manufactured since the late 1980's, and have application in such diverse areas as sonar and non-destructive testing. One manufacturer (Imasonic, Besancon, FR) builds custom composite HIFU applicators which are used by several research and commercial organizations. Popularly known as piezocomposites, these materials are made by taking solid blocks of piezoelectric ceramic, dicing the block into a forest of tall, thin pillars of ceramic, and backfilling the dicing kerfs with a polymer. This composite ceramic/polymer material is then processed like a normal solid transducer ceramic into thin plates. The volume fraction of the composite is controlled by the dicing kerf width and spacing, and the composite material properties can thereby be tailored to specific applications.
[0011] While many superior properties of composites are exploited in diagnostic imaging, the chief interest for HIFU is the ability to form composites into arbitrary shapes. In diagnostic imaging, the superior piezoelectric and acoustic properties of composites are exploited to produce wideband frequency responses, which are of little interest in HIFU at this time. Flexible polymer materials are often used as composite fillers which allow the material to be easily manipulated into cylindrical or spherical shapes. However, flexible composites are inherently high loss materials and unsuitable to the high power levels used in HIFU. Flexible materials would distort and ultimately disintegrate due to the heat build-up inside the material itself under high drive levels. Using less flexible polymers as composite filler materials would increase the composites' power handling capabilities due to lower intrinsic loss mechanisms, but would then make forming the composite into a curved shape seemingly impossible. '
[0012] The answer to this dilemma is to make use of an interesting property of many hardset epoxies: these materials can be heated at a relatively low temperature into a partially cured state (namely, a B-stage cure) that is quite hard, but fairly brittle. In this state, the material can be processed, that is diced, filled, ground, lapped, and electroded into the thin sheets needed for HIFU applicators, and then reheated to a temperature somewhat above the original B-stage cure temperature. At this point, the polymer softens considerably and can be clamped into a mold shaped to the configuration desired (for instance, a spherically shaped bowl or vortex shape) and reheated to a much higher temperature. The epoxy filler then will fully cure, and further heat treatment can elevate the epoxy glass transition temperature, the temperature at which the polymer suddenly will soften, to levels between 120° and 200°C. The material thus formed is relatively low loss and capable of handling HIFU power levels, albeit with less efficiency than solid, high power, piezoelectric ceramics.
[0013] While requiring custom molds and clamping equipment, ultimately it is easier and cheaper to produce ceramic elements this way than to grind them directly using expensive equipment or hand labor; the elements are more rugged as well, which is a very important consideration. The lower efficiency is not expected to be a limitation in fat lysis since higher frequencies can be used for the small treatment depths, and thus high intensities can be achieved with relatively low drive levels. This is easily demonstrated by considering the fact that the intensity antenna gain for a focused radiator increases as the square of the frequency. An optimum frequency for HIFU at a given depth of focus can be obtained from the following equation:
f opt = (2az) ,
where fopt is the optimum frequency, α is the ultrasonic absorption of fat, and z is the tissue depth to be treated. For fat treated at 2 cm of depth, the optimum frequency for maximum heat deposition is 4.2 MHz. Other considerations may change the actual operating frequency, of course.
[0014] Clearly the marriage of a technique of increasing the focal area of a HIFU applicator like the vortex concept and a means of easily and cheaply implementing this interesting structure like piezocomposites can reduce the overall treatment time for lysing large volumes of adipose tissue. Reducing treatment time and cost are key areas which will determine the fate of lysis commercialization efforts.
[0015] Sector-vortex array design has been extensively described and simulated by Cain and Umemura, Umemura and Cain, and numerous papers from Hynynen and co-workers at Brigham's and Women's Hospital at Harvard. They describe an implementation whereby the driving electrode of a spherical radiator is divided into N number of equal sized, pie-shaped sectors. Following Cain, driving signals are applied to the N sectors with a phase distribution over the N sectors determined by:
Figure imgf000007_0001
for / = 1 ,2,...N where m is the vortex mode number, and θι =i2π/N. The phase distribution over the N sectors is such that that the excitation field rotates around the radiator at a phase velocity ωofm. When N is large, an approximate analytic expression for the acoustic field in the focal plane can be derived; this field has a shape determined by the mth order Bessel function. The vortex-shaped field is zero along the central axis for m ≠ 0, and has a diameter proportional to the vortex mode m. The field in cross-section resembles an annulus with side lobes at radii greater than the annulus.
[0016] However sector- vortex designs require complex electronics to drive the transducers in order to produce the vortex focal field. The electronics are required to drive either sector transducers or phased arrays in sequence. Some prior teachings rely on ancillary technologies such as the use of MRI machines to detect hotspots, and provide for additional electronic to provide real time corrections in the electronic firing of the various transducer elements to eliminate or reduce the occurrence of out-of-field ultrasound excitation. Complex lenses have also been described to facilitate the steering of the ultrasound energy into the body.
[0017] Thus there remains a need in the art for a robust vortex transducer, having a simplified design that can operate without the requirement of complex and expensive electronics.
[0018] There is further a need for a vortex transducer that can be aimed without the use of a lens.
[0019] There is still further a need for a vortex transducer having a fast activation and treatment time for reliably depositing a fixed amount of energy into a focal zone. BRIEF SUMMARY OF THE INVENTION [0020] Some of the needs of the art are addressed by the present disclosure. In accordance with the needs of the art, it is an objective of the present invention to provide a transducer capable of producing a vortex focal zone.
[0021] It is further an objective to provide a transducer able to create a vortex focal zone without the use of complex electronics.
[0022] It is still further an objective of the present invention to be able to reliably aim a vortex transducer without using a lens or electronic steering.
[0023] Yet another objective is to provide for a vortex transducer with a cheap and cost effective manufacturing process.
[0024] One or more of the above objectives is met utilizing a mechanically formed vortex ultrasound transducer capable of producing at least one, substantially annular focal region when the transducer is excited.
[0025] In a second embodiment there is a mechanically formed ultrasound transducer comprising a plurality of piezoelectric elements suspended in a polymer, and having an irregular shape in order to produce a vortex focal field.
[0026] The polymer used in the creation of a heat set transducer shape has a liquid state when introduced into a diced piezoelectric ceramic, a semi solid state during processing and a fixed solid state upon completion of a heat treatment step.
[0027] A method of manufacturing is disclosed comprising the steps of first shaping a piezoelectric ceramic into a desired form, the form having a front end and a back end. Second dicing the front end to create a plurality of elements, the elements being attached to the back end and separated by dicing channels. Third, filling the dicing channels with a polymer material and allowing the polymer to gel. Fourth, creating a transducer form by removing the back end such that the elements are separated from one another. Fifth, pressing the transducer form into a mold and heating the transducer form such that the resin is heated above the B- stage and allowing the resin to cross-link and cool in a set shape. Sixth, treating at least one surface of the transducer form with a conductive material such that all elements are in contact with the conductive material. An additional step involves the formation of a shaped irregularity to produce the vortex effect. This step can be inserted into the steps above where ever desired and there is no best order for the introduction of this step. The shaped irregularity can be part of the original forming of the transducer form, or it can be created later by cutting or grinding the transducer form such that the desired irregularity is introduced.
BRIEF DESCRIPTION OF THE DRAWINGS [0028] Fig. 1 is a histological view of a HIFU lesion in porcine adipose tissue at 40X magnification.
[0029] Fig 2 is a histological view of a HIFU lesion in porcine adipose tissue at 200X magnification.
[0030] Fig. 3 is a schematic illustration of a vortex ultrasound transducer/applicator design in accordance with the present invention.
[0031] Figs. 4a-4d show a cross-sectional focal zone intensity distributions for a series of sector- vortex applicators, modes 0 through 3, demonstrating the annular structure of the field patterns and the widening of the annulus as a function of mode number.
[0032] Figs. 5a and 5b is a further illustration of an embodiment of the present invention.
[0033] Figs. 6a-6g illustrate a process for making transducers in accordance with the present invention.
DETAILED DESCRIPTION OF THE INVENTION [0034] Described herein is an implementation of a version of the sector- vortex concept. While this concept is known, this disclosure implements the design in a novel manner. In order to avoid the complexities and cost of an electronic beamformer, or the use of a sector- vortex lens with its attendant issues in reliability, acoustic losses and reverberations, and cooling, a continuous vortex lens can be incorporated into the piezoelectric transducer material itself. This can be done by building the transducer out of piezoelectric composite material which can be molded into a vortex lens. This eliminates the need for complex driving electronics and all the issues of an external lens. This design could be instrumental in building cheap, reliable devices that can potentially reduce treatment time by factors of two to eight.
[0035] The present invention implements an applicator design that incorporates the phase shifts mechanically, not electronically. This is mathematically equivalent to letting N-→oo, that is letting the number of sectors become infinite, or making a continuously curving shape, as shown in Fig. 3, that yields a 2πm phase shift after one revolution. The applicator would also be preset with spherical focus. As one can see, this shape would be difficult to machine in a solid piezoelectric ceramic material. But one can easily imagine molding a piezocomposite into this shape using steel molds manufactured with a ball end mill or EDM (electric discharge machining) machine. Fig. 3 also illustrates the generic shape of a continuously variable sector-vortex applicator made by splitting a spherical bowl along a radius and translating one split edge axially in relationship to the other edge.
[0036] A 2π phase shift (mode number = 1) corresponds to one wavelength of the driving frequency; at 4 MHz in water, this is 380 μm. Thus, for mode 1, the discontinuity at the split on the edge of the spherical bowl would then be 380 μm, mode 2, 760 μm, and so on.
Splitting a spherical bowl made of piezocomposite along one radial line, and forming it with a discontinuity on the order of 1 mm is possible, but represents the major technical challenge in the proposed project.
[0037] Fig. 4a-4d show the cross-sectional focal patterns for modes 0, 1, 2, and 3, respectively. Mode 0 reduces just to the simple spherical radiator, and serves as the standard by which to judge the increase in focal zone area in other designs.
[0038] Theoretically, the field along the central axis of the sector- vortex applicator is zero and would not contribute to tissue lysis. However, heat generated in the annulus will flow into this region and will not have ready access to a heat sink. It is expected, if the annulus is not too large, that the temperature will rise to therapeutic levels under interesting drive conditions, forming a large solid lesion.
[0039] Based on the proceeding description, it is possible to produce a vortex transducer. The present invention comprises a mechanically formed vortex ultrasound transducer capable of producing at least one, substantially annular focal region(s) when said transducer is excited. The transducer may incorporate a solid piezoelectric material or a composite piezoelectric material. Furthermore the transducer may incorporate one or more matching layers. The transducer may incorporate a filler material in front of the transducer or backing material in back of the transducer. The transducer may also be formed from a single contiguous piezoelectric element. See Figs. 5a & 5b, where the reference numbers are as follows:
1. Back electrode connection and wire
2. Electrical connector 3. Transducer housing
4. Backing material
5. Piezoelectric element
5 a. Matching layer(s) on front of piezoelectric element 6a.-6b. Fluid inlet and outlet for cooling
7. Front electrode connection and wire
8. Filler material
9. Face material
10. Piezoelectric material [0040] A method of making the transducer of the present invention is also provided. The method comprises the steps of: first shaping a piezoelectric ceramic into a desired form, the form having a front end and a back end. Second dicing the front end create a plurality of elements, the elements being attached to the back end and separated by dicing channels. Third filling the dicing channels with a resin material and allowing the resin to gel. Fourth, creating a transducer form by removing the back end such that the elements are separated from one another. Fifth, pressing the transducer form into a mold and heating the transducer form such thai the resin is heated above the B-state and allowing the resin to cross link and cool in a set shape. Sixth, treating at least one surface of the transducer form with a conductive material such that all elements are in contact with the conductive material. An additional step involves the formation of a shaped irregularity to produce the vortex effect. This step can be inserted into the steps above where ever desired and there is no best order for the introduction of this step. The shaped irregularity can be part of the original forming of the transducer form, or it can be created later by cutting or grinding the transducer form such that the desired irregularity is introduced.
[0041] The manner of producing the transducer is detailed below. First, the piezoelectric material is formed into a desired form (Fig. 6a). The form may include the irregularity used to mechanically create the vortex transducer effect, or the irregularity can be introduced into the finished transducer form. The shaping of the piezoelectric ceramic into a desired form follows procedures well established in the art of making ultrasound transducers. The principal embodiment calls for a flat shape having sufficient size to be later molded into the desired three dimensional form. Otherwise there is no restriction or requirement on the formation process. Similarly the dicing of the ceramic is also well known. In the second step the ceramic is diced such that there is sufficient depth in the dicing channels to allow a resin like material to fill the channels (Fig. 6b). The filling of the channels with a polymer ( e.g. epoxy or urethane) provides a solid material to support and maintain the elements in a fixed position relative to one another (Fig. 6c). Once the polymer is set sufficiently to hold the elements in place without the structural support of the ceramic back plate, the back plate is removed (Fig. 6d). Now the transducer form comprises the individual elements and the polymer used to suspend the elements and hold them in place.
[0042] The resulting two-phase composite material can be tailored to have a number of interesting electro-mechanical and purely mechanical properties by the choice of parameters like ceramic volume fraction and polymer filler material. Of particular interest in permanently forming piezocomposities into interesting shapes is the use of hardset (high durometer) thermoset resin systems such as epoxy as the polymer filler. The set epoxy in the composite can be partially cured at a relatively low temperature where it "gels," or turns substantially solid from a liquid state. At a slightly higher temperature, the epoxy can then progress into a B-stage partially cross-linked cure which is quite hard, but very brittle. At this level the piezocomposite can be processed easily by grinding to a thickness as a flat plate and applying electrodes. As a final step, the piezocomposite can then be reheated slightly past the B-stage temperature where it softens considerably and can be formed into shapes. Commonly, the piezocomposite is placed in a warm bottom half of a mold that allows the plate to take the shape of the mold, a top half of the mold is then clamped to the bottom half, and then the mold is heated to a high final curing temperature. At this point, the epoxy filler cures to a fully cross-linked, tempered, stage over a period of time determined by the resin system. The resulting molded piezocomposite now has a shape that takes on the shape of a lens. In this manner, a piezoelectrically active lens can be made that is quite rugged, eliminating the need for separate focusing lenses.
[0043] The next step provides an essential process step of the present invention. That is the molding of the transducer form to shape the elements and polymer (epoxy) combination into a shaped transducer (Fig. 6e). The form selected will dictate the focal range, depth and shape of the ultrasound focal zone. Thus the mold must be carefully determined and created since it is not possible to electronically steer the transducer when it is completed. When the transducer form is in the mold, the mold and transducer form are heated until the resin/epoxy is heated past the B-stage of the filler material. This makes the epoxy/resin softer so the transducer form can be properly shaped. The final shaped transducer (Fig. 6f) is then coated with a conductive material and electronically connected (Fig. 6g) to an activation device such as a high voltage supply (not shown).
[0044] The reference numbers used in Figs. 6a-6g are as follows:
10a Piezoelectric ceramic 10b Dized ceramic
10c Filled w/epoxy 13
1 Od Back removed lOe Heat molding
1 Of planar transducer w/irregularity lOg Heat molded w/irregularity and conductive layer 12 and electrical connection 14
[0045] The transducer can be made to operate either narrowband (roughly, at one frequency) or broadband (over a range of frequencies). The decision on narrow or broadband will be left to the designer to choose based on the specific application. The designer should consider the beam pattern the vortex transducer will produce before finalizing the design. The beam shape will produce a double funnel focus field similar to that described in the prior art; however, with the simplified transducer of the present invention, there will be no need for complex electronics to steer or focus the beam, or run a complex pattern of individual element activations.
[0046] Additional modifications and variations of the present invention are possible in light of the above teachings and the description provided herein is not to be meant as limiting the invention to the descriptions provided. It is understood those skilled in the art will be able to utilize the present teaching without substantial variation, and such practices are within the intended scope of the present invention and the appended claims.

Claims

WHAT IS CLAIMED IS:
L A mechanically formed vortex ultrasound transducer capable of producing at least one, substantially annular focal region(s) when said transducer is excited.
2. The transducer of claim 1 where the transducer incorporates a solid piezoelectric material.
3. The transducer of claim 1 where the transducer incorporates a composite piezoelectric material.
4. The transducer of claim 1 where the transducer incorporates one or more matching layers.
5. The transducer of claim 1 where the transducer incorporates a filler material in front of the transducer or backing material in back of the transducer.
6. The transducer of claim 1 , being formed of a single contiguous piezoelectric element.
7. A mechanically formed ultrasound transducer comprising a plurality of piezoelectric elements suspended in a polymer and having an irregular shape such that a vortex focal field is produced when the transducer is excited.
8. A polymer for use in the creation of a heat set transducer shape having a liquid state when introduced into a diced piezoelectric ceramic, a semi solid state during processing and a fixed solid state upon completion of a heat treatment step.
9. The polymer of claim 8, wherein the polymer is an epoxy.
10. A system for producing a vortex ultrasound focal field comprising: a mechanically formed ultrasound transducer having an irregular shape for creating said vortex; and an activation switch.
11. A method of creating a vortex transducer comprising the steps of: (a) shaping a piezoelectric ceramic into a desired form, the form having a front end and a back end; (b) dicing said front end create a plurality of elements, said elements being attached to said back end and separated by dicing channels; (c) filling said dicing channels with an epoxy material and allowing said epoxy to gel; (d) creating a transducer form by removing said back end such that said elements are separated from one another; (e) pressing said transducer form into a mold and heating said transducer form such that the epoxy is heated above the B-stage and allowing the resin to cross link and cool in a set shape; (f) treating at least one surface of the transducer form with a conductive material such that all elements are in contact with said conductive material; and (g) making a shape irregularity in the transducer form such that the transducer will produce a vortex effect.
12. The method of claim 11 , wherein step (g) may be performed before performing any one of steps (a)-(f).
PCT/US2004/010253 2003-03-31 2004-03-31 Vortex transducer WO2004089188A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2006509648A JP2006521902A (en) 2003-03-31 2004-03-31 Vortex transducer
EP04749694A EP1608267A4 (en) 2003-03-31 2004-03-31 Vortex transducer

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US45935503P 2003-03-31 2003-03-31
US60/459,355 2003-03-31
US48331703P 2003-06-26 2003-06-26
US60/483,317 2003-06-26

Publications (2)

Publication Number Publication Date
WO2004089188A2 true WO2004089188A2 (en) 2004-10-21
WO2004089188A3 WO2004089188A3 (en) 2005-05-12

Family

ID=33162205

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/010253 WO2004089188A2 (en) 2003-03-31 2004-03-31 Vortex transducer

Country Status (4)

Country Link
US (2) US7273459B2 (en)
EP (1) EP1608267A4 (en)
JP (1) JP2006521902A (en)
WO (1) WO2004089188A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2811092A1 (en) * 2020-07-20 2021-03-10 Univ Valencia Politecnica SOLIDS CONTROLLED FRAGMENTATION SYSTEM USING ACOUSTIC VORTEX BEAMS (Machine-translation by Google Translate, not legally binding)

Families Citing this family (118)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6050943A (en) 1997-10-14 2000-04-18 Guided Therapy Systems, Inc. Imaging, therapy, and temperature monitoring ultrasonic system
JP4723732B2 (en) * 2000-07-12 2011-07-13 セイコーインスツル株式会社 Pulse detection device and ultrasonic diagnostic device
US7914453B2 (en) 2000-12-28 2011-03-29 Ardent Sound, Inc. Visual imaging system for ultrasonic probe
EP1608267A4 (en) * 2003-03-31 2007-04-25 Liposonix Inc Vortex transducer
AU2004279458B2 (en) 2003-10-10 2009-12-10 Cook Incorporated Fenestrated stent grafts
US8235909B2 (en) 2004-05-12 2012-08-07 Guided Therapy Systems, L.L.C. Method and system for controlled scanning, imaging and/or therapy
US7393325B2 (en) * 2004-09-16 2008-07-01 Guided Therapy Systems, L.L.C. Method and system for ultrasound treatment with a multi-directional transducer
US7824348B2 (en) 2004-09-16 2010-11-02 Guided Therapy Systems, L.L.C. System and method for variable depth ultrasound treatment
US9011336B2 (en) 2004-09-16 2015-04-21 Guided Therapy Systems, Llc Method and system for combined energy therapy profile
US10864385B2 (en) 2004-09-24 2020-12-15 Guided Therapy Systems, Llc Rejuvenating skin by heating tissue for cosmetic treatment of the face and body
US7530958B2 (en) 2004-09-24 2009-05-12 Guided Therapy Systems, Inc. Method and system for combined ultrasound treatment
US8444562B2 (en) 2004-10-06 2013-05-21 Guided Therapy Systems, Llc System and method for treating muscle, tendon, ligament and cartilage tissue
US8535228B2 (en) 2004-10-06 2013-09-17 Guided Therapy Systems, Llc Method and system for noninvasive face lifts and deep tissue tightening
CA2583600A1 (en) 2004-10-06 2006-04-20 Guided Therapy Systems, L.L.C. Method and system for noninvasive cosmetic enhancement
US11883688B2 (en) 2004-10-06 2024-01-30 Guided Therapy Systems, Llc Energy based fat reduction
US9694212B2 (en) 2004-10-06 2017-07-04 Guided Therapy Systems, Llc Method and system for ultrasound treatment of skin
US8690778B2 (en) 2004-10-06 2014-04-08 Guided Therapy Systems, Llc Energy-based tissue tightening
DK1855759T3 (en) 2004-10-06 2017-06-06 Guided Therapy Systems Llc Tissue Ultrasound Treatment System
US7758524B2 (en) 2004-10-06 2010-07-20 Guided Therapy Systems, L.L.C. Method and system for ultra-high frequency ultrasound treatment
US11235179B2 (en) 2004-10-06 2022-02-01 Guided Therapy Systems, Llc Energy based skin gland treatment
US20060111744A1 (en) 2004-10-13 2006-05-25 Guided Therapy Systems, L.L.C. Method and system for treatment of sweat glands
US9827449B2 (en) 2004-10-06 2017-11-28 Guided Therapy Systems, L.L.C. Systems for treating skin laxity
US8133180B2 (en) 2004-10-06 2012-03-13 Guided Therapy Systems, L.L.C. Method and system for treating cellulite
US11207548B2 (en) 2004-10-07 2021-12-28 Guided Therapy Systems, L.L.C. Ultrasound probe for treating skin laxity
US11724133B2 (en) 2004-10-07 2023-08-15 Guided Therapy Systems, Llc Ultrasound probe for treatment of skin
US20060122509A1 (en) * 2004-11-24 2006-06-08 Liposonix, Inc. System and methods for destroying adipose tissue
US8277495B2 (en) 2005-01-13 2012-10-02 Candela Corporation Method and apparatus for treating a diseased nail
US8218477B2 (en) * 2005-03-31 2012-07-10 Alcatel Lucent Method of detecting wireless network faults
EP1875327A2 (en) 2005-04-25 2008-01-09 Guided Therapy Systems, L.L.C. Method and system for enhancing computer peripheral saftey
US9486274B2 (en) 2005-09-07 2016-11-08 Ulthera, Inc. Dissection handpiece and method for reducing the appearance of cellulite
US20090093737A1 (en) * 2007-10-09 2009-04-09 Cabochon Aesthetics, Inc. Ultrasound apparatus with treatment lens
US8518069B2 (en) 2005-09-07 2013-08-27 Cabochon Aesthetics, Inc. Dissection handpiece and method for reducing the appearance of cellulite
US10548659B2 (en) 2006-01-17 2020-02-04 Ulthera, Inc. High pressure pre-burst for improved fluid delivery
US9011473B2 (en) 2005-09-07 2015-04-21 Ulthera, Inc. Dissection handpiece and method for reducing the appearance of cellulite
US7967763B2 (en) * 2005-09-07 2011-06-28 Cabochon Aesthetics, Inc. Method for treating subcutaneous tissues
US9358033B2 (en) 2005-09-07 2016-06-07 Ulthera, Inc. Fluid-jet dissection system and method for reducing the appearance of cellulite
US8057408B2 (en) 2005-09-22 2011-11-15 The Regents Of The University Of Michigan Pulsed cavitational ultrasound therapy
US10219815B2 (en) 2005-09-22 2019-03-05 The Regents Of The University Of Michigan Histotripsy for thrombolysis
EP2796168B1 (en) 2005-09-28 2017-09-06 Candela Corporation Treating cellulite
US9248317B2 (en) 2005-12-02 2016-02-02 Ulthera, Inc. Devices and methods for selectively lysing cells
US7885793B2 (en) 2007-05-22 2011-02-08 International Business Machines Corporation Method and system for developing a conceptual model to facilitate generating a business-aligned information technology solution
US7891362B2 (en) 2005-12-23 2011-02-22 Candela Corporation Methods for treating pigmentary and vascular abnormalities in a dermal region
US7828734B2 (en) * 2006-03-09 2010-11-09 Slender Medical Ltd. Device for ultrasound monitored tissue treatment
US20090048514A1 (en) * 2006-03-09 2009-02-19 Slender Medical Ltd. Device for ultrasound monitored tissue treatment
US9107798B2 (en) * 2006-03-09 2015-08-18 Slender Medical Ltd. Method and system for lipolysis and body contouring
US9566454B2 (en) 2006-09-18 2017-02-14 Guided Therapy Systems, Llc Method and sysem for non-ablative acne treatment and prevention
US9241683B2 (en) 2006-10-04 2016-01-26 Ardent Sound Inc. Ultrasound system and method for imaging and/or measuring displacement of moving tissue and fluid
US8382689B2 (en) * 2007-02-08 2013-02-26 St. Jude Medical, Atrial Fibrillation Division, Inc. Device and method for high intensity focused ultrasound ablation with acoustic lens
US8102734B2 (en) * 2007-02-08 2012-01-24 St. Jude Medical, Atrial Fibrillation Division, Inc. High intensity focused ultrasound transducer with acoustic lens
US20080195003A1 (en) * 2007-02-08 2008-08-14 Sliwa John W High intensity focused ultrasound transducer with acoustic lens
US7877854B2 (en) * 2007-02-08 2011-02-01 St. Jude Medical, Atrial Fibrillation Division, Inc. Method of manufacturing an ultrasound transducer
US20080243035A1 (en) * 2007-03-26 2008-10-02 Liposonix, Inc. Interchangeable high intensity focused ultrasound transducer
DK2152167T3 (en) 2007-05-07 2018-12-10 Guided Therapy Systems Llc Methods and systems for coupling and focusing acoustic energy using a coupling element
US20150174388A1 (en) 2007-05-07 2015-06-25 Guided Therapy Systems, Llc Methods and Systems for Ultrasound Assisted Delivery of a Medicant to Tissue
TWI526233B (en) * 2007-05-07 2016-03-21 指導治療系統股份有限公司 Methods and systems for modulating medicants using acoustic energy
US20090093723A1 (en) * 2007-10-05 2009-04-09 Cabochon Aesthetics, Inc. Ultrasound device including dispenser
US20090093738A1 (en) * 2007-10-09 2009-04-09 Cabochon Aesthetics, Inc. Device and method for monitoring a treatment area
US8439940B2 (en) 2010-12-22 2013-05-14 Cabochon Aesthetics, Inc. Dissection handpiece with aspiration means for reducing the appearance of cellulite
US20090099483A1 (en) * 2007-10-11 2009-04-16 Andrey Rybyanets Apparatus and method for ultrasound treatment
US20100274161A1 (en) * 2007-10-15 2010-10-28 Slender Medical, Ltd. Implosion techniques for ultrasound
US20090240146A1 (en) * 2007-10-26 2009-09-24 Liposonix, Inc. Mechanical arm
US8206326B2 (en) 2008-03-04 2012-06-26 Sound Surgical Technologies, Llc Combination ultrasound-phototherapy transducer
US20090230823A1 (en) * 2008-03-13 2009-09-17 Leonid Kushculey Operation of patterned ultrasonic transducers
US8466605B2 (en) * 2008-03-13 2013-06-18 Ultrashape Ltd. Patterned ultrasonic transducers
CN104545998B (en) 2008-06-06 2020-07-14 奥赛拉公司 System and method for cosmetic treatment and imaging
US20110178541A1 (en) * 2008-09-12 2011-07-21 Slender Medical, Ltd. Virtual ultrasonic scissors
US9050449B2 (en) * 2008-10-03 2015-06-09 Mirabilis Medica, Inc. System for treating a volume of tissue with high intensity focused ultrasound
US20100106063A1 (en) * 2008-10-29 2010-04-29 Cabochon Aesthetics, Inc. Ultrasound Enhancing Target for Treating Subcutaneous Tissue
KR20110101204A (en) 2008-12-24 2011-09-15 가이디드 테라피 시스템스, 엘.엘.씨. Methods and systems for fat reduction and/or cellulite treatment
US20100168582A1 (en) * 2008-12-29 2010-07-01 Boston Scientific Scimed, Inc. High frequency transducers and methods of making the transducers
US8167280B2 (en) * 2009-03-23 2012-05-01 Cabochon Aesthetics, Inc. Bubble generator having disposable bubble cartridges
US20100256596A1 (en) * 2009-04-07 2010-10-07 Cabochon Aesthetics, Inc. Fiber growth promoting implants for reducing the appearance of cellulite
US20100286518A1 (en) * 2009-05-11 2010-11-11 General Electric Company Ultrasound system and method to deliver therapy based on user defined treatment spaces
US20100286520A1 (en) * 2009-05-11 2010-11-11 General Electric Company Ultrasound system and method to determine mechanical properties of a target region
US20100286519A1 (en) * 2009-05-11 2010-11-11 General Electric Company Ultrasound system and method to automatically identify and treat adipose tissue
US8888706B2 (en) * 2009-08-04 2014-11-18 National Health Research Institutes Dual-curvature phased array high-intensity focused ultrasound transducer for tumor therapy
US9358064B2 (en) 2009-08-07 2016-06-07 Ulthera, Inc. Handpiece and methods for performing subcutaneous surgery
US11096708B2 (en) 2009-08-07 2021-08-24 Ulthera, Inc. Devices and methods for performing subcutaneous surgery
WO2011022411A2 (en) 2009-08-17 2011-02-24 Histosonics, Inc. Disposable acoustic coupling medium container
AU2010289775B2 (en) 2009-08-26 2016-02-04 Histosonics, Inc. Devices and methods for using controlled bubble cloud cavitation in fractionating urinary stones
US9943708B2 (en) 2009-08-26 2018-04-17 Histosonics, Inc. Automated control of micromanipulator arm for histotripsy prostate therapy while imaging via ultrasound transducers in real time
US8539813B2 (en) 2009-09-22 2013-09-24 The Regents Of The University Of Michigan Gel phantoms for testing cavitational ultrasound (histotripsy) transducers
US8715186B2 (en) 2009-11-24 2014-05-06 Guided Therapy Systems, Llc Methods and systems for generating thermal bubbles for improved ultrasound imaging and therapy
US20110184322A1 (en) * 2010-01-22 2011-07-28 Slender Medical Ltd. Method and device for treatment of keloids and hypertrophic scars using focused ultrasound
TW201208734A (en) 2010-07-24 2012-03-01 Medicis Technologies Corp Apparatus and methods for non-invasive body contouring
US10183182B2 (en) 2010-08-02 2019-01-22 Guided Therapy Systems, Llc Methods and systems for treating plantar fascia
US9504446B2 (en) 2010-08-02 2016-11-29 Guided Therapy Systems, Llc Systems and methods for coupling an ultrasound source to tissue
CN103153399B (en) * 2010-08-18 2016-08-10 米瑞碧利斯医疗公司 HIFU spreader
US8857438B2 (en) 2010-11-08 2014-10-14 Ulthera, Inc. Devices and methods for acoustic shielding
US8858471B2 (en) 2011-07-10 2014-10-14 Guided Therapy Systems, Llc Methods and systems for ultrasound treatment
KR20190080967A (en) 2011-07-11 2019-07-08 가이디드 테라피 시스템스, 엘.엘.씨. Systems and methods for coupling an ultrasound source to tissue
US9144694B2 (en) 2011-08-10 2015-09-29 The Regents Of The University Of Michigan Lesion generation through bone using histotripsy therapy without aberration correction
US9049783B2 (en) 2012-04-13 2015-06-02 Histosonics, Inc. Systems and methods for obtaining large creepage isolation on printed circuit boards
US9263663B2 (en) 2012-04-13 2016-02-16 Ardent Sound, Inc. Method of making thick film transducer arrays
EP2844343B1 (en) 2012-04-30 2018-11-21 The Regents Of The University Of Michigan Ultrasound transducer manufacturing using rapid-prototyping method
US9510802B2 (en) 2012-09-21 2016-12-06 Guided Therapy Systems, Llc Reflective ultrasound technology for dermatological treatments
WO2014055906A1 (en) 2012-10-05 2014-04-10 The Regents Of The University Of Michigan Bubble-induced color doppler feedback during histotripsy
US9289188B2 (en) 2012-12-03 2016-03-22 Liposonix, Inc. Ultrasonic transducer
CN204637350U (en) 2013-03-08 2015-09-16 奥赛拉公司 Aesthstic imaging and processing system, multifocal processing system and perform the system of aesthetic procedure
US10561862B2 (en) 2013-03-15 2020-02-18 Guided Therapy Systems, Llc Ultrasound treatment device and methods of use
WO2015003154A1 (en) 2013-07-03 2015-01-08 Histosonics, Inc. Articulating arm limiter for cavitational ultrasound therapy system
WO2015003142A1 (en) 2013-07-03 2015-01-08 Histosonics, Inc. Histotripsy excitation sequences optimized for bubble cloud formation using shock scattering
US9574916B2 (en) 2013-07-23 2017-02-21 Yokogawa Corporation Of America Optimized techniques for generating and measuring toroidal vortices via an industrial vortex flowmeter
US9243940B2 (en) * 2013-07-23 2016-01-26 Yokogawa Corporation Of America Optimized techniques for generating and measuring toroidal vortices via an industrial vortex flowmeter
WO2015027164A1 (en) 2013-08-22 2015-02-26 The Regents Of The University Of Michigan Histotripsy using very short ultrasound pulses
KR102461535B1 (en) 2014-04-04 2022-10-31 포토소닉스 메디컬, 인크. Methods, devices and systems for treating bacteria with mechanical stress energy and electromagnetic energy
SG11201608691YA (en) 2014-04-18 2016-11-29 Ulthera Inc Band transducer ultrasound therapy
US10959826B2 (en) 2014-10-16 2021-03-30 Cook Medical Technology LLC Support structure for scalloped grafts
WO2016168385A2 (en) 2015-04-14 2016-10-20 Photosonix Medical, Inc. Method and device for treatment with combination ultrasound-phototherapy transducer
WO2016210133A1 (en) 2015-06-24 2016-12-29 The Regents Of The Universtiy Of Michigan Histotripsy therapy systems and methods for the treatment of brain tissue
AU2017208980B2 (en) 2016-01-18 2022-03-31 Ulthera, Inc. Compact ultrasound device having annular ultrasound array peripherally electrically connected to flexible printed circuit board and method of assembly thereof
KR102593310B1 (en) 2016-08-16 2023-10-25 얼테라, 인크 Ultrasound imaging system configured to reduce imaging misalignment, ultrasound imaging module, and method for reducing imaging misalignment
US11944849B2 (en) 2018-02-20 2024-04-02 Ulthera, Inc. Systems and methods for combined cosmetic treatment of cellulite with ultrasound
CN113286552A (en) 2018-11-28 2021-08-20 希斯托索尼克斯公司 Histotripsy system and method
CA3169465A1 (en) 2020-01-28 2021-08-05 The Regents Of The University Of Michigan Systems and methods for histotripsy immunosensitization
CN111740223B (en) * 2020-07-06 2021-05-28 中国科学院成都生物研究所 Method for synthesizing vortex electromagnetic field with high orbital angular momentum mode number
CN112911464B (en) * 2021-01-18 2021-10-19 中国科学院成都生物研究所 Method and device for generating super-mode number synthetic vortex sound field
KR20240010587A (en) * 2022-07-14 2024-01-24 동국대학교 산학협력단 Aircoupled vortex ultrasound probe module for improving hearing function and ultrasound imaging system using the same

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5402792A (en) 1993-03-30 1995-04-04 Shimadzu Corporation Ultrasonic medical apparatus
US5873845A (en) 1997-03-17 1999-02-23 General Electric Company Ultrasound transducer with focused ultrasound refraction plate

Family Cites Families (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB820814A (en) 1955-12-22 1959-09-30 Univ Illinois Apparatus for treating living tissue
US4002221A (en) * 1972-09-19 1977-01-11 Gilbert Buchalter Method of transmitting ultrasonic impulses to surface using transducer coupling agent
US4059098A (en) * 1975-07-21 1977-11-22 Stanford Research Institute Flexible ultrasound coupling system
DE2826277C2 (en) * 1978-06-15 1980-07-17 Siemens Ag, 1000 Berlin Und 8000 Muenchen Device for ultrasonic scanning of objects
US4211949A (en) * 1978-11-08 1980-07-08 General Electric Company Wear plate for piezoelectric ultrasonic transducer arrays
US4326418A (en) * 1980-04-07 1982-04-27 North American Philips Corporation Acoustic impedance matching device
DE3021449A1 (en) * 1980-06-06 1981-12-24 Siemens AG, 1000 Berlin und 8000 München ULTRASONIC TRANSDUCER ARRANGEMENT AND METHOD FOR THE PRODUCTION THEREOF
US4368410A (en) * 1980-10-14 1983-01-11 Dynawave Corporation Ultrasound therapy device
US4459854A (en) * 1981-07-24 1984-07-17 National Research Development Corporation Ultrasonic transducer coupling member
JPS6015212Y2 (en) * 1982-07-26 1985-05-14 株式会社モリタ製作所 Light arm balance mechanism
US4593699A (en) * 1983-06-13 1986-06-10 Poncy Richard P Sterile cover for intraoperative ultrasonic diagnostic devices and method and kit for providing same
US4556066A (en) * 1983-11-04 1985-12-03 The Kendall Company Ultrasound acoustical coupling pad
US4567895A (en) * 1984-04-02 1986-02-04 Advanced Technology Laboratories, Inc. Fully wetted mechanical ultrasound scanhead
US4640291A (en) 1985-06-27 1987-02-03 North American Philips Corporation Bi-plane phased array for ultrasound medical imaging
US4865042A (en) * 1985-08-16 1989-09-12 Hitachi, Ltd. Ultrasonic irradiation system
EP0310380B2 (en) * 1987-09-30 1997-04-02 Kabushiki Kaisha Toshiba Ultrasonic medical treatment apparatus
US5143063A (en) * 1988-02-09 1992-09-01 Fellner Donald G Method of removing adipose tissue from the body
JP2602923B2 (en) 1988-10-31 1997-04-23 株式会社東芝 Shock wave therapy device
US5400788A (en) * 1989-05-16 1995-03-28 Hewlett-Packard Apparatus that generates acoustic signals at discrete multiple frequencies and that couples acoustic signals into a cladded-core acoustic waveguide
EP0462311B1 (en) * 1990-06-21 1995-04-05 Siemens Aktiengesellschaft Composite ultrasound transducer and fabrication process of a structured component from piezoelectric ceramic
DE9012429U1 (en) * 1990-08-30 1990-10-31 Johnson & Johnson Medical Gmbh, 2000 Norderstedt, De
FR2679125B1 (en) 1991-07-19 1993-11-26 Technomed International USE OF AT LEAST ONE COMPOSITE PIEZOELECTRIC TRANSDUCER FOR THE MANUFACTURE OF AN ULTRASONIC THERAPY APPARATUS FOR THERAPY IN PARTICULAR OF CONCRETIONS, FABRICS OR BONES OF A LIVING BEING.
US5253648A (en) * 1991-10-11 1993-10-19 Spacelabs Medical, Inc. Method and apparatus for excluding artifacts from automatic blood pressure measurements
US5871446A (en) * 1992-01-10 1999-02-16 Wilk; Peter J. Ultrasonic medical system and associated method
DE4212809C2 (en) * 1992-04-16 1996-08-14 Siemens Ag Therapy device for treating a living being with focused acoustic waves
JP3270527B2 (en) * 1992-07-08 2002-04-02 呉羽化学工業株式会社 Cylindrical or curved piezoelectric element
US5434208A (en) * 1992-07-10 1995-07-18 Akzo Nobel N.V. Optically non-linear active waveguiding material comprising a dopant having multiple donor-n-acceptor systems
CA2074424A1 (en) * 1992-07-22 1994-01-23 Bryce L. Fanning Acoustic gel
US5352301A (en) * 1992-11-20 1994-10-04 General Motors Corporation Hot pressed magnets formed from anisotropic powders
DE4241161C2 (en) * 1992-12-07 1995-04-13 Siemens Ag Acoustic therapy facility
US5738635A (en) * 1993-01-22 1998-04-14 Technomed Medical Systems Adjustable focusing therapeutic apparatus with no secondary focusing
DE4302538C1 (en) * 1993-01-29 1994-04-07 Siemens Ag Ultrasonic therapy device for tumour treatment lithotripsy or osteorestoration - with ultrasonic imaging and ultrasonic treatment modes using respective acoustic wave frequencies
US6535794B1 (en) * 1993-02-23 2003-03-18 Faro Technologoies Inc. Method of generating an error map for calibration of a robot or multi-axis machining center
DE4408110A1 (en) * 1993-03-11 1994-09-15 Zentralinstitut Fuer Biomedizi Method and device for neuromagnetic stimulation
US5477736A (en) * 1994-03-14 1995-12-26 General Electric Company Ultrasonic transducer with lens having electrorheological fluid therein for dynamically focusing and steering ultrasound energy
US5623928A (en) * 1994-08-05 1997-04-29 Acuson Corporation Method and apparatus for coherent image formation
US5695501A (en) * 1994-09-30 1997-12-09 Ohio Medical Instrument Company, Inc. Apparatus for neurosurgical stereotactic procedures
US6152137A (en) * 1995-01-23 2000-11-28 Schwartz; Alan N. Pliable and resilient sealing pad
US5626554A (en) * 1995-02-21 1997-05-06 Exogen, Inc. Gel containment structure
DE19507478C1 (en) * 1995-03-03 1996-05-15 Siemens Ag Therapy device for treatment with focused ultrasound
US5755753A (en) * 1995-05-05 1998-05-26 Thermage, Inc. Method for controlled contraction of collagen tissue
DE19681395T1 (en) * 1995-05-16 1998-04-16 Brown & Sharpe Mfg Coordinate measuring machine with articulated arm
AU2997095A (en) * 1995-06-20 1997-01-22 Wan Sing Ng Articulated arm for medical procedures
US5738098A (en) * 1995-07-21 1998-04-14 Hewlett-Packard Company Multi-focus ultrasound lens
US5568810A (en) * 1995-11-28 1996-10-29 General Electric Company Ultrasound coupling medium warmer and storage means
JP2001517101A (en) * 1996-02-26 2001-10-02 エチコン・エンド―サージエリー・インコーポレーテツド Medical articulated guide arm
US6241703B1 (en) * 1996-08-19 2001-06-05 Angiosonics Inc. Ultrasound transmission apparatus having a tip
US5769790A (en) * 1996-10-25 1998-06-23 General Electric Company Focused ultrasound surgery system guided by ultrasound imaging
US5676159A (en) * 1996-11-05 1997-10-14 Janin Group Ultrasound cover
US5938922A (en) * 1997-08-19 1999-08-17 Celgard Llc Contactor for degassing liquids
US6113558A (en) * 1997-09-29 2000-09-05 Angiosonics Inc. Pulsed mode lysis method
US6071239A (en) * 1997-10-27 2000-06-06 Cribbs; Robert W. Method and apparatus for lipolytic therapy using ultrasound energy
WO1999037213A1 (en) 1998-01-23 1999-07-29 United States Surgical Corporation Surgical instrument
US6039689A (en) * 1998-03-11 2000-03-21 Riverside Research Institute Stripe electrode transducer for use with therapeutic ultrasonic radiation treatment
US6261249B1 (en) * 1998-03-17 2001-07-17 Exogen Inc. Ultrasonic treatment controller including gel sensing circuit
FR2778573B1 (en) * 1998-05-13 2000-09-22 Technomed Medical Systems FREQUENCY ADJUSTMENT IN A HIGH INTENSITY FOCUSED ULTRASOUND TREATMENT APPARATUS
US6039694A (en) * 1998-06-25 2000-03-21 Sonotech, Inc. Coupling sheath for ultrasound transducers
JP3321103B2 (en) * 1998-09-04 2002-09-03 ジーイー横河メディカルシステム株式会社 Image display method and ultrasonic diagnostic apparatus
US6302848B1 (en) * 1999-07-01 2001-10-16 Sonotech, Inc. In vivo biocompatible acoustic coupling media
KR100275500B1 (en) * 1998-10-28 2000-12-15 정선종 Fabrication method of integrated high voltage power institute
US6308146B1 (en) * 1998-10-30 2001-10-23 J. D. Edwards World Source Company System and method for simulating user input to control the operation of an application
US6312386B1 (en) * 1999-02-19 2001-11-06 Acuson Corporation Medical ultrasound imaging system with composite delay profile
US6214703B1 (en) * 1999-04-15 2001-04-10 Taiwan Semiconductor Manufacturing Company Method to increase wafer utility by implementing deep trench in scribe line
US6233476B1 (en) * 1999-05-18 2001-05-15 Mediguide Ltd. Medical positioning system
US6142748A (en) * 1999-08-18 2000-11-07 Eastman Chemical Company Degas piping for pumps
US6306146B1 (en) 2000-04-06 2001-10-23 Ohio Medical Instrument Company, Inc. Surgical instrument support and method
US6613004B1 (en) * 2000-04-21 2003-09-02 Insightec-Txsonics, Ltd. Systems and methods for creating longer necrosed volumes using a phased array focused ultrasound system
US6554826B1 (en) * 2000-04-21 2003-04-29 Txsonics-Ltd Electro-dynamic phased array lens for controlling acoustic wave propagation
US6419648B1 (en) * 2000-04-21 2002-07-16 Insightec-Txsonics Ltd. Systems and methods for reducing secondary hot spots in a phased array focused ultrasound system
US6506171B1 (en) * 2000-07-27 2003-01-14 Insightec-Txsonics, Ltd System and methods for controlling distribution of acoustic energy around a focal point using a focused ultrasound system
US6508171B1 (en) * 2000-08-03 2003-01-21 Chris Georges Illuminated transparent article having a semi-transparent image thereon
US6618620B1 (en) * 2000-11-28 2003-09-09 Txsonics Ltd. Apparatus for controlling thermal dosing in an thermal treatment system
US7347855B2 (en) * 2001-10-29 2008-03-25 Ultrashape Ltd. Non-invasive ultrasonic body contouring
US6607498B2 (en) * 2001-01-03 2003-08-19 Uitra Shape, Inc. Method and apparatus for non-invasive body contouring by lysing adipose tissue
US6575906B1 (en) * 2001-04-19 2003-06-10 Acuson Corporation Rapid-heating ultrasound gel warmer
US6561389B1 (en) * 2001-07-31 2003-05-13 Walter R. Earle Dispenser apparatus for medical grade ultrasound gel
CA2476873A1 (en) 2002-02-20 2003-08-28 Liposonix, Inc. Ultrasonic treatment and imaging of adipose tissue
US6807498B2 (en) * 2002-02-22 2004-10-19 Texas Instruments Incorporated Method for measuring PLL lock time
EP1608267A4 (en) * 2003-03-31 2007-04-25 Liposonix Inc Vortex transducer

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5402792A (en) 1993-03-30 1995-04-04 Shimadzu Corporation Ultrasonic medical apparatus
US5873845A (en) 1997-03-17 1999-02-23 General Electric Company Ultrasound transducer with focused ultrasound refraction plate

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1608267A4

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2811092A1 (en) * 2020-07-20 2021-03-10 Univ Valencia Politecnica SOLIDS CONTROLLED FRAGMENTATION SYSTEM USING ACOUSTIC VORTEX BEAMS (Machine-translation by Google Translate, not legally binding)
WO2022018311A1 (en) * 2020-07-20 2022-01-27 Universitat Politècnica De València System for the controlled fragmentation of solids by means of vortex sound beams

Also Published As

Publication number Publication date
EP1608267A4 (en) 2007-04-25
US20040217675A1 (en) 2004-11-04
US20070035201A1 (en) 2007-02-15
EP1608267A2 (en) 2005-12-28
US7273459B2 (en) 2007-09-25
WO2004089188A3 (en) 2005-05-12
US7766848B2 (en) 2010-08-03
JP2006521902A (en) 2006-09-28

Similar Documents

Publication Publication Date Title
US7273459B2 (en) Vortex transducer
US8162858B2 (en) Ultrasonic medical treatment device with variable focal zone
US20120143100A1 (en) Extended depth-of-focus high intensity ultrasonic transducer
CA2719175C (en) Operation of patterned ultrasonic transducers
CN101460119B (en) Apparatus for the destruction of adipose tissue
US8466605B2 (en) Patterned ultrasonic transducers
US7674233B2 (en) Method and apparatus for focussing ultrasonic energy
Fan et al. Control of the necrosed tissue volume during noninvasive ultrasound surgery using a 16‐element phased array
WO2016134581A1 (en) Dual-frequency confocal superimposed focused ultrasonic spherical splitting array and control method for splitting focus points
EP1360685B1 (en) Ultrasound transducer and method of manufacturing an ultrasound transducer
Sasaki et al. Effect of split-focus approach on producing larger coagulation in swine liver
US11305133B2 (en) Efficient acoustic energy transfer through skull via excitation of Lamb waves
Jeong et al. Dual-focus therapeutic ultrasound transducer for production of broad tissue lesions
Fjield et al. Low-profile lenses for ultrasound surgery
Li et al. A study of heating duration and scanning path in focused ultrasound surgery
Woo et al. Design and fabrication of an annular array high intensity focused ultrasound transducer with an optimal electrode pattern
Cheng et al. Split‐focused ultrasound transducer with multidirectional heating for breast tumor thermal surgery
Kwon et al. Phase-Inverted Multifrequency HIFU Transducer for Lesion Expansion: A Simulation Study
CN207270580U (en) A kind of single-curved surface strip power ultrasonic device with three-dimensional imaging probe
Gupta et al. Transient temperature study during 3D scanning in HIFU thermal ablation
Li et al. Dual-focus scanning in volumetric HIFU ablation: Preliminary simulation study
Chen et al. Design and fabrication of high-intensity focused ultrasound phased array for liver tumor therapy
González et al. Ultrasonic Hyperthermia
Lobstein-Adams Development of a medical imaging-based technology for cancer treatment
Vincenot et al. Two large focal zones can be created using a toroidal transducer for increasing the coagulated volume

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2006509648

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2004749694

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2004749694

Country of ref document: EP